↓ Skip to main content
What is this page? Embed badge

Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BEST)

Overview of attention for article published in Trials, May 2011
Altmetric Badge

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
34 Mendeley
Summary Dimensions citations
So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.